Showing results (911-920 of 927) with videos related to
Sort By:
Pageof 93
The Pediatric Infectious Disease Journal|August 29, 2012
Reactogenicity and immunogenicity of an enterovirus 71 vaccine in Chinese healthy children and infantsFeng-Cai Zhu, Jun-Zhi Wang, Xiu-Ling Li, et al.Chemistry & Biology|July 28, 2010
Application of chemoproteomics to drug discovery: identification of a clinical candidate targeting hsp90Patrick Fadden, Kenneth H Huang, James M Veal, et al.Journal of Global Antimicrobial Resistance|July 17, 2025
Emerging epidemic of the predominant clusters of FC428-like Neisseria gonorrhoeae in Guangdong, ChinaYang Chen, Xiao-Lin Qin, Han Zhou, et al.Science Bulletin|September 24, 2023
Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trialYue-Mei Hu, Zhao-Feng Bi, Ya Zheng, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 14, 2022
Podocalyxin-Like Protein 1 Regulates Pluripotency through the Cholesterol Biosynthesis PathwayWei-Ju Chen, Wei-Kai Huang, Sarshan R Pather, et al.NPJ Precision Oncology|July 7, 2025
Transcriptional profiling clarifies a program of enzalutamide extreme non-response in lethal prostate cancerAnbarasu Kumaraswamy, Ya-Mei Hu, Joel A Yates, et al.Journal of Medicinal Chemistry|June 26, 2009
Discovery of novel 2-aminobenzamide inhibitors of heat shock protein 90 as potent, selective and orally active antitumor agentsKenneth H Huang, James M Veal, R Patrick Fadden, et al.Lancet (London, England)|June 4, 2013
Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trialFeng-Cai Zhu, Fan-Yue Meng, Jing-Xin Li, et al.Emerging Microbes & Infections|October 26, 2022
A novel RBD-protein/peptide vaccine elicits broadly neutralizing antibodies and protects mice and macaques against SARS-CoV-2Shixia Wang, Chang Yi Wang, Hui-Kai Kuo, et al.Nature Communications|September 15, 2022
Transcriptional profiling of matched patient biopsies clarifies molecular determinants of enzalutamide-induced lineage plasticityThomas C Westbrook, Xiangnan Guan, Eva Rodansky, et al.Pageof 93